Accellent in-market with $193 million term loan B repricing

By Sara Rosenberg

New York, March 17 - Accellent Inc., formerly known as UTI Corp., is in-market with a repricing of its $193 million six-year term loan B at Libor plus 225 basis points, according to a syndicate document.

Credit Suisse First Boston and Wachovia are joint lead arrangers on the deal.

The deal launched via a conference call on Tuesday.

Accellent is a Collegeville, Pa., provider of metal and plastic components, assemblies and finished devices to medical device manufacturers.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.